Meeting slides
Interactive presentation

Osteoarthritis Pathophysiology and Novel Treatment Targets

Presented by Jeffrey Gudin, MD
Suggested Readings

Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say?

Cooper C, et al. Drugs Aging. 2019;36(Suppl 1):15-24.

The efficacy, tolerability, and joint safety of fasinumab in osteoarthritis pain: a phase iib/iii double-blind, placebo-controlled, randomized clinical trial.

Dakin P, et al. Arthritis Rheumatol. 2019;71(11):1824-1834.

Nerve growth factor and pain mechanisms.

Denk F, et al. Annu Rev Neurosci. 2017;40:307-325.

CDC guideline for prescribing opioids for chronic pain — United States, 2016.

Dowell D, et al. MMWR Recomm Rep. 2016;65(1):1-49.

Enhanced recovery protocols in total joint arthroplasty: a review of the literature and their implementation.

Galbraith AS, et al. Ir J Med Sci. 2018;187(1):97-109.

Gandhi R, et al. CMAJ. 2014;186(5):347‐355.

Surgical management of hip osteoarthritis.


Hunter DJ, Bierma-Zeinstra S. Lancet. 2019;393(10182):1745-1759.

Knee osteoarthritis: a review of management options.

Hussain SM, et al. Scott Med J. 2016;61(1):7‐16.

Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys.

Pelletier JP, et al. Semin Arthritis Rheum. 2016;45(suppl 4):S22-S27.

Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial.

Schnitzer TJ, et al. JAMA. 2019;322(1):37-48.

Nonsurgical management of osteoarthritis knee pain in the older adult.

Taylor N. Clin Geriatr Med. 2017;33(1):41‐51.

Related activities
1.00 CME

Finding Relief in Osteoarthritis

New Paths to Chronic Pain Management

Faculty: Scott A. Rodeo, MD; Thomas J. Schnitzer, MD, PhD
Release: 10/06/2020
Expiration: 10/06/2021